feed,title,long_url,short_url
Benzinga,UniQure Shares Are Up After Low-Dose Cohort Data From Huntington's Gene Therapy Trial,https://benzinga.com/general/biotech/22/06/27830566/uniqure-shares-are-up-after-low-dose-cohort-data-from-huntingtons-gene-therapy-trial,https://bit.ly/3tXJhC9
Benzinga,Raymond James Upgrades Frontier Group - Read Why,https://benzinga.com/news/22/06/27833369/raymond-james-upgrades-frontier-group,https://bit.ly/3Ognj5K
